Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2018 Oct 4:2018:9316162.
doi: 10.1155/2018/9316162. eCollection 2018.

Association between Serum Copeptin and Stroke in Rural Areas of Northern China: A Matched Case-Control Study

Affiliations

Association between Serum Copeptin and Stroke in Rural Areas of Northern China: A Matched Case-Control Study

Hao Sun et al. Dis Markers. .

Abstract

Background: Copeptin has been implicated as an effective prognostic biomarker of stroke outcome; however, few studies have investigated whether copeptin could be used as an etiological factor for stroke or not. The aim of our study was to evaluate the association of serum copeptin with stroke.

Methods: In total, 238 participants including 119 cases (87 ischemic stroke and 32 hemorrhagic stroke) and 119 controls were included in this 1 : 1 matched case-control study. Conditional multivariate logistic regression was conducted to assess the Odds Ratios (ORs) and 95% confidence intervals (CI); restricted cubic spline in logistic regression model was used to evaluate the dose-response association between serum copeptin and total stroke, ischemic stroke, and hemorrhagic stroke.

Results: The median serum copeptin was 20.90 pmol/L, 20.90 pmol/L, 6.53 pmol/L, and 8.42 pmol/L for total stroke, ischemic stroke, hemorrhagic stroke, and healthy subjects, respectively. The corresponding ORs (95% CIs) for the highest compared with the lowest quartile were 1.23 (0.62-2.44) for total stroke, 4.01 (1.47-10.96) for ischemic stroke, and 0.13 (0.22-0.69) for hemorrhagic stroke. No nonlinear dose-response relationship was found between serum copeptin and total stroke (P nonlinear = 0.278), ischemic stroke (P nonlinear = 0.362), and hemorrhagic stroke (P nonlinear = 0.314). Compared with the reference copeptin level, a significantly increasing trend was found between serum copeptin and ischemic stroke (P overall = 0.002), and a decreasing trend was found between serum copeptin and hemorrhagic stroke (P overall = 0.007).

Conclusions: Elevated serum copeptin levels were positively associated with ischemic stroke and adversely associated with hemorrhagic stroke. Additional prospective studies with larger sample size are needed to confirm the present findings.

PubMed Disclaimer

Figures

Figure 1
Figure 1
The plot of dose-response relationship between serum copeptin and total stroke (Pnonlinear = 0.278, Poverall = 0.139; adjusted by personal history of hypertension, smoking status, and pickle intake).
Figure 2
Figure 2
The plot of dose-response relationship between serum copeptin and ischemic stroke (Pnonlinear = 0.362, Poverall = 0.002; adjusted by BMI, personal history of hypertension, smoking status, and pickle intake).
Figure 3
Figure 3
The plot of dose-response relationship between serum copeptin and hemorrhagic stroke (Pnonlinear = 0.314, Poverall = 0.007).

Similar articles

Cited by

References

    1. Johnston S. C., Mendis S., Mathers C. D. Global variation in stroke burden and mortality: estimates from monitoring, surveillance, and modelling. The Lancet. Neurology. 2009;8(4):345–354. doi: 10.1016/S1474-4422(09)70023-7. - DOI - PubMed
    1. Wang Z., Li J., Wang C., et al. Gender differences in 1-year clinical characteristics and outcomes after stroke: results from the China National Stroke Registry. PLoS One. 2013;8(2, article e56459) doi: 10.1371/journal.pone.0056459. - DOI - PMC - PubMed
    1. Wang W., Jiang B., Sun H., et al. Prevalence, incidence, and mortality of stroke in China: results from a nationwide population-based survey of 480 687 adults. Circulation. 2017;135(8):759–771. doi: 10.1161/CIRCULATIONAHA.116.025250. - DOI - PubMed
    1. Dunser M. W., Wenzel V., Mayr A. J., Hasibeder W. R. Management of vasodilatory shock: defining the role of arginine vasopressin. Drugs. 2003;63(3):237–256. doi: 10.2165/00003495-200363030-00001. - DOI - PubMed
    1. Baumann G., Dingman J. F. Distribution, blood transport, and degradation of antidiuretic hormone in man. The Journal of Clinical Investigation. 1976;57(5):1109–1116. doi: 10.1172/JCI108377. - DOI - PMC - PubMed